Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
The temperature is heating up around Novo Holdings’ acquisition of contract manufacturer Catalent, as consumer and union groups write to the Federal Trade Commission to
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
The latest round of layoffs will see Sage reduce 33% of its total workforce. Credits: Wirestock Creators/Shutterstock.com After a series of mid-stage clinical trial failures,
Patients with opioid use disorder (OUD) had a lower risk of discontinuing methadone compared with buprenorphine/naloxone, and with a similar mortality risk, according to a
WASHINGTON — Use of a “virtual” emergency department (ED) has saved several patients from unnecessary ED trips in its first few weeks of operation, Sidney
The FDA approved zolbetuximab (Vyloy), a claudin 18.2 (CLDN18.2)-directed cytolytic antibody, in combination with chemotherapy for the first-line treatment of adults with advanced HER2-negative gastric
A healthy diet in prostate cancer patients on active surveillance was associated with a reduced risk of progressing to a more advanced disease state. (JAMA